Stay updated on Resmetirom Safety and Biomarkers Clinical Trial

Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:41:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Minor editorial updates: the Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the page revision is listed as Revision: v3.3.1 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:45:36.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:55:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new publication citation was added to the Publications section: Alkhouri N, McRae MP, Taub R, Hill B, Imperial JC, Kittelson J, Moussa SE, Everson GT. The Cholate Challenge Test Quantified Baseline Functional Heterogeneity and Improvement in Response to Resmetirom in MASH-related Child-Pugh A Cirrhosis. Gastro Hep Adv. 2025 Aug 29;4(10):100785. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:18:45.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government-funding status notice and operating status links, impacting user expectations about timeliness and support. - Added a new resource entry: Generalized resistance to thyroid hormone under the Genetic and Rare Diseases Information Center resources. - Updated revision to v3.2.0 (from v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T10:21:04.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.3%
    Check dated 2025-09-28T03:21:37.000Z thumbnail image

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.